Tizona Therapeutics, Inc. . Full-time Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Tizona Therapeutics, Inc. is a biotechnology company focused on immunology, developing therapies intended to treat cancer and autoimmune diseases. Its programs seek to modulate the activity of immunosuppressive cells, aiming to boost the body's ability to combat cancer or to prevent immune attack on healthy tissues. The company was founded by MPM Capital alongside scientists from leading institutions, and operates from South San Francisco, California.

Positioned in the biotechnology research space, it pursues novel immunotherapies that address immune suppression within the tumor microenvironment and self-reactivity in autoimmune disease. Its activities are oriented toward collaborations with pharmaceutical and research partners seeking to advance immunotherapy programs. A notable development in its history is a 2020 strategic alliance with Gilead Sciences, whereby Gilead acquired a 49.9% equity stake and holds an exclusive option to acquire the remaining interest.

Sign up for free to view info

Company overview Employee directory